Aaron Katz, P.C.

Prior to joining Kirkland, Aaron was involved in the following representative matters:

Trials

• Trial counsel to a privately owned healthcare technology company in a non-intervened False Claims Act matter involving allegations of cybersecurity vulnerabilities.
• Trial counsel to a biotechnology subsidiary of a publicly traded medical device company in a criminal matter involving charges of wire fraud and violations of the Food, Drug and Cosmetic Act.
• Trial counsel to a global reinsurance company in a coverage dispute arising from decades of chemical contamination of New York’s Niagara River Basin.
• Trial counsel to the founder and executive chairman of a publicly traded pharmaceutical company in a criminal RICO matter involving allegations of kickbacks and insurance fraud.
• Trial counsel to a real estate investor charged with wire fraud relating to the sale of environmentally contaminated land to Wynn Resorts.
• Trial counsel to a BP petroleum engineer charged with obstruction of justice in the first criminal prosecution brought by the Department of Justice’s Deepwater Horizon Task Force.
• Trial counsel to a Deutsche Bank precious metals trader in the first “spoofing” prosecution charged under the wire fraud statute.
• Trial counsel to a venture capital fund executive accused by the SEC of manipulating the prices of OTC-traded securities.
• Trial counsel to the president of a check-cashing company charged with conspiracy to defraud the IRS and violations of the Bank Secrecy Act’s currency transaction reporting requirements.
• Trial counsel to the co-founder of a dental services management organization charged with violations of the RICO statute, healthcare fraud and money laundering.
  

Pre-Trial Litigation and Investigations

• Counsel to a PE-owned healthcare technology company in a putative class action involving Russian hackers’ theft and illicit publication of patients’ pre- and post-operative photographs from a well-known plastic surgery clinic in Los Angeles.
• Counsel to a publicly traded pharmaceutical company in the largest-ever non-intervened False Claims Act action.
• Counsel to a home health company executive in DOJ Antitrust Division criminal price-fixing and market-carving investigation.
• Counsel to plaintiffs in a lawsuit against a leading video games and e-sports company for violations of Section 1 and Section 2 of the Sherman Act.
• Lead counsel for a Greek shipping company executive indicted by DOJ for bribing a United Nations official in Romania, raising novel questions about the extraterritorial reach of 18 U.S.C. 666.
• Advisor to the sponsor and board of directors of a PE-owned medical device company under investigation by the U.S. Attorney’s Office for the Southern District of New York for alleged violations of the False Claims Act.
• Counsel to a publicly traded healthcare technology company in a groundbreaking civil and criminal investigation involving the promotion of opioids through “clinical decision support” alerts.
• Counsel to a PE-owned healthcare technology company in a False Claims Act investigation and lawsuit involving allegations of kickbacks and violations of HITECH Act regulations.
• Class counsel in a breach-of-contract class action brought by a natural food manufacturer against one of the country’s largest natural food distributors.
• Counsel to a hedge fund in a lawsuit involving claims of misuse of IPO proceeds.
• Counsel to a PE-owned healthcare technology company in a civil RICO lawsuit brought by one of the country’s largest health insurers, alleging a conspiracy to violate the Anti-Kickback Statute with respect to multiple sclerosis medications.
• Counsel to a PE-owned hospital chain in a non-intervened False Claims Act lawsuit involving allegations of medically unnecessary invasive and non-invasive cardiac procedures.
• Counsel to a PE-owned home healthcare services provider in a non-intervened False Claims Act lawsuit alleging fabricated reimbursement claims.
• Counsel to a publicly traded pharmaceutical company in a non-intervened False Claims Act lawsuit alleging a conspiracy with pharmacy benefit managers to inflate the price of specialty drugs.
• Counsel to a parent charged in the “Varsity Blues” college admissions scandal.
• Counsel to an investor charged in the Southern District of New York’s prosecution of the Blacklight platform.
• Counsel to a leading pharmacy benefits manager in a False Claims Act investigation conducted by the U.S. Attorney’s Office for the Southern District of New York.
• Counsel to a nationwide pharmacy in several intervened and non-intervened False Claims Act lawsuits alleging violations of the Anti-Kickback Statute.
• Counsel to a global reinsurance company in a toxic tort action involving respiratory disease allegedly caused by manganese welding fumes.
  

Litigation Risk and Compliance Assessments

• Advises leading private equity firms in valuing the litigation and investigation portfolios of target companies.
• Advises hedge funds in predicting the outcomes of lawsuits involving publicly traded companies.
• Advises private equity sponsors on compliance program improvements for portfolio companies.
• Conducts compliance reviews for pharmaceutical, medical device and healthcare companies.

Founding Partner, Aaron Katz Law LLC

Partner, Ropes & Gray LLP

Counsel to death row inmates in Alabama, including Iraq War veteran Courtney Lockhart, in partnership with the Equal Justice Initiative.

Counsel to numerous international dog rescue organizations in an Administrative Procedure Act challenge to newly promulgated regulatory restrictions on the importation dogs from rabies-free countries.